California-based Jazz Pharmaceuticals JAZZ will raise as much as $58.5 million in a secondary share offering. The company plans to sell 7 million shares to the public at a price of $8.35 a share.
The stock is currently trading for $8.44. Barclays Capital BCS is managing the offering, which closes on Friday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in